Middle East & Africa Extracorporeal CO2 Removal Devices Market Size and Forecast (2021 - 2031)
The Middle East & Africa (MEA) Extracorporeal CO2 Removal Devices Market is projected to grow significantly, reaching an estimated US$ 4.8 million by 2031, up from US$ 3.2 million in 2024, with a compound annual growth rate (CAGR) of 6.1% anticipated from 2025 to 2031.
Executive Summary and Market Analysis
The market for Extracorporeal CO2 Removal Devices (ECCO2R) in the MEA region is primarily segmented into key countries: the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Currently, ECCO2R remains largely experimental, utilized selectively in urban, tertiary, or academic hospitals. There are limited institutional adoptions, with only a few documented case reports and pilot studies. For example, a notable case in Egypt involved a patient with severe Chronic Obstructive Pulmonary Disease (COPD) who, after failing non-invasive ventilation, was treated with a low-flow ECCO2R device (Hemolung), successfully avoiding intubation. This case, along with experiences from South Africa, highlights the potential for ECCO2R even in less-equipped settings.
Despite these promising instances, the adoption of ECCO2R is hindered by several factors. The lack of trained personnel in advanced life support beyond Extracorporeal Membrane Oxygenation (ECMO) poses a significant challenge, as ECCO2R requires specialized training. Furthermore, the regulatory and reimbursement landscape for ECCO2R in many MEA countries is unclear, with insufficient guidelines for its implementation in conditions like Acute Respiratory Distress Syndrome (ARDS) or COPD exacerbations.
On a positive note, the rising incidence of respiratory diseases, exacerbated by urban air pollution and the COVID-19 pandemic, has increased the demand for advanced respiratory support technologies. Some private and academic hospitals in the UAE, Saudi Arabia, South Africa, and Egypt are among the first to adopt ECCO2R technology, exploring its use not only as a last resort but also as a preventive measure against ventilator-induced lung injury.
Market Segmentation
The MEA Extracorporeal CO2 Removal Devices Market is segmented by product, application, and end user:
The increasing prevalence of respiratory diseases underscores the urgent need for innovative therapeutic solutions. Chronic respiratory diseases, particularly COPD, are among the leading global health challenges, causing approximately 4 million deaths annually, according to the Institute for Health Metrics and Evaluation (2019). Projections indicate that by 2050, the number of COPD cases could reach 600 million, driven by aging populations, pollution, and smoking.
Obesity, a significant risk factor for respiratory diseases, further complicates treatment outcomes. The World Health Organization reported that in 2022, around 2.5 billion adults were overweight, with over 890 million classified as obese. This trend is particularly concerning in low- and middle-income countries, where healthcare infrastructure may be less developed.
Manufacturers are responding to this health crisis by developing and marketing ECCO2R devices aimed at patients suffering from acute hypercapnic respiratory failure. These devices offer a critical intervention for patients experiencing elevated carbon dioxide levels in the blood, providing relief and improving prognoses.
The combination of rising respiratory disease cases, obesity-related complications, and advancements in ECCO2R technology is expected to drive market growth. As healthcare providers and manufacturers work together to address existing challenges, ECCO2R systems are likely to become integral to respiratory care, offering hope to patients amid a global health crisis.
Country Insights
By country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East & Africa, with Saudi Arabia holding the largest market share in 2024. Awareness of ECCO2R technology in Saudi Arabia is still developing, primarily associated with ECMO practices rather than as a standalone therapy. The Saudi Critical Care Society has recognized ECCO2R in national guidelines for ARDS, but practical protocols for its use remain underdeveloped.
Despite the challenges, including limited clinical trials and high device costs, the existing infrastructure for ECMO in Saudi Arabia provides a foundation for ECCO2R adoption. Training programs are being implemented to enhance healthcare professionals' skills, which may facilitate the integration of ECCO2R into clinical practice.
Company Profiles
Key players in the MEA Extracorporeal CO2 Removal Devices Market include Terumo Corp, Medtronic Plc, Baxter International Inc, LivaNova Plc, Getinge AB, Fresenius Medical Care AG & Co KGaA, Eurosets SRL, Aferetica s.r.l., Medica S.p.A., and ESTOR S.P.A. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Research Methodology
The report's data collection and analysis involved comprehensive secondary research, utilizing various sources, including company reports, industry publications, and government documents. Primary research included interviews with industry stakeholders to validate findings and gain insights into market dynamics.
Executive Summary and Market Analysis
The market for Extracorporeal CO2 Removal Devices (ECCO2R) in the MEA region is primarily segmented into key countries: the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Currently, ECCO2R remains largely experimental, utilized selectively in urban, tertiary, or academic hospitals. There are limited institutional adoptions, with only a few documented case reports and pilot studies. For example, a notable case in Egypt involved a patient with severe Chronic Obstructive Pulmonary Disease (COPD) who, after failing non-invasive ventilation, was treated with a low-flow ECCO2R device (Hemolung), successfully avoiding intubation. This case, along with experiences from South Africa, highlights the potential for ECCO2R even in less-equipped settings.
Despite these promising instances, the adoption of ECCO2R is hindered by several factors. The lack of trained personnel in advanced life support beyond Extracorporeal Membrane Oxygenation (ECMO) poses a significant challenge, as ECCO2R requires specialized training. Furthermore, the regulatory and reimbursement landscape for ECCO2R in many MEA countries is unclear, with insufficient guidelines for its implementation in conditions like Acute Respiratory Distress Syndrome (ARDS) or COPD exacerbations.
On a positive note, the rising incidence of respiratory diseases, exacerbated by urban air pollution and the COVID-19 pandemic, has increased the demand for advanced respiratory support technologies. Some private and academic hospitals in the UAE, Saudi Arabia, South Africa, and Egypt are among the first to adopt ECCO2R technology, exploring its use not only as a last resort but also as a preventive measure against ventilator-induced lung injury.
Market Segmentation
The MEA Extracorporeal CO2 Removal Devices Market is segmented by product, application, and end user:
- By Product: The market is divided into Extracorporeal CO2 Devices and Consumables, with the former dominating in 2024.
- By Application: The primary applications include Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and others, with COPD being the leading segment.
- By End User: The market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and others, where Hospitals and Clinics held the largest share in 2024.
The increasing prevalence of respiratory diseases underscores the urgent need for innovative therapeutic solutions. Chronic respiratory diseases, particularly COPD, are among the leading global health challenges, causing approximately 4 million deaths annually, according to the Institute for Health Metrics and Evaluation (2019). Projections indicate that by 2050, the number of COPD cases could reach 600 million, driven by aging populations, pollution, and smoking.
Obesity, a significant risk factor for respiratory diseases, further complicates treatment outcomes. The World Health Organization reported that in 2022, around 2.5 billion adults were overweight, with over 890 million classified as obese. This trend is particularly concerning in low- and middle-income countries, where healthcare infrastructure may be less developed.
Manufacturers are responding to this health crisis by developing and marketing ECCO2R devices aimed at patients suffering from acute hypercapnic respiratory failure. These devices offer a critical intervention for patients experiencing elevated carbon dioxide levels in the blood, providing relief and improving prognoses.
The combination of rising respiratory disease cases, obesity-related complications, and advancements in ECCO2R technology is expected to drive market growth. As healthcare providers and manufacturers work together to address existing challenges, ECCO2R systems are likely to become integral to respiratory care, offering hope to patients amid a global health crisis.
Country Insights
By country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East & Africa, with Saudi Arabia holding the largest market share in 2024. Awareness of ECCO2R technology in Saudi Arabia is still developing, primarily associated with ECMO practices rather than as a standalone therapy. The Saudi Critical Care Society has recognized ECCO2R in national guidelines for ARDS, but practical protocols for its use remain underdeveloped.
Despite the challenges, including limited clinical trials and high device costs, the existing infrastructure for ECMO in Saudi Arabia provides a foundation for ECCO2R adoption. Training programs are being implemented to enhance healthcare professionals' skills, which may facilitate the integration of ECCO2R into clinical practice.
Company Profiles
Key players in the MEA Extracorporeal CO2 Removal Devices Market include Terumo Corp, Medtronic Plc, Baxter International Inc, LivaNova Plc, Getinge AB, Fresenius Medical Care AG & Co KGaA, Eurosets SRL, Aferetica s.r.l., Medica S.p.A., and ESTOR S.P.A. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Research Methodology
The report's data collection and analysis involved comprehensive secondary research, utilizing various sources, including company reports, industry publications, and government documents. Primary research included interviews with industry stakeholders to validate findings and gain insights into market dynamics.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 Middle East & Africa
10.1.1 Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
10.4.5.5 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 Middle East & Africa
10.1.1 Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
10.4.5.5 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Product
10.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by Application
10.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Heat Map Analysis by Key Players
Table 1. Middle East & Africa Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East & Africa Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East & Africa Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Middle East & Africa Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Middle East & Africa Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Company Positioning & Concentration
Figure 1. Middle East & Africa Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. Middle East & Africa Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East & Africa Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Middle East & Africa Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Middle East & Africa Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. Saudi Arabia: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. South Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. United Arab Emirates: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Rest of Middle East & Africa: Middle East & Africa Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Company Positioning & Concentration
